UPMC Cancer Centers Network Trials

UPMC Cancer Centers Network	Welcome, Profile Billing Logout

UPMC Cancer Centers Network

Welcome, Profile Billing Logout

1 Trial

1 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Zeh, Herbert J

Precision Promise, NCT04229004: A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer

Active, not recruiting

825

Gemcitabine combined with nab-paclitaxel, Dose -mFOLFIRINOX, Dose - Pamrevlumab combined with gemcitabine and nab-paclitaxel, Dose- Canakinumab and Spartalizumab combined with nab-paclitaxel and gemcitabine, Drug: Dose -SM-88

Pancreatic Cancer Action Network

Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma

06/27

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites